METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m<sup>6</sup>A modification of ANKRD22 mRNA

Lvyuan Li(Central South University), Wei Xiong(Central South University), Qianjin Liao(Hunan Normal University), Bo Xiang(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Yongzhen Mo(Central South University), Can Guo(Central South University), Dan Wang(First Affiliated Hospital of Zhengzhou University), Yumin Wang(King University), Fang Xiong(Craft Group (China)), Lei Shi(Central South University), Ming Zhou(Central South University), Fuyan Wang(Central South University), Zhaoyang Zeng(Central South University), Qiling Tang(Central South University), Pan Chen(Central South University), Junshang Ge(Central South University), Yijie Zhang(Central South University), Qijia Yan(Central South University)
Clinical and Translational Medicine
July 1, 2024
10.1002/ctm2.1766
Cited by 26

Related Papers

The cancer metabolic reprogramming and immune response
|Molecular Cancer|2021|1.3k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578